Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease

Holger Kessler(Saarland University), Thomas A. Bayer(Brown University), Peter Falkai(Ludwig-Maximilians-Universität München), Rima Obeid(Saarland University), P. Meisser(Saarland University), Wolfgang Herrmann(Saarland University), Gerhard Multhaup(McGill University), Kristine Hoffmann(Saarland University), Frank–Gerald Pajonk(Saarland University), Tillmann Supprian(University of Würzburg)
Journal of Neural Transmission
May 30, 2006
10.1007/s00702-006-0485-7
Cited by 80

Related Papers

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Mind Reading: Neural Mechanisms of Theory of Mind and Self-Perspective
|NeuroImage|2001|1k
EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)
|European Psychiatry|2018|662
Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia
|FEBS Letters|2006|488
Homocysteine and Dementia: An International Consensus Statement
|Journal of Alzheimer s Disease|2018|360